Avelox Bayer Healthcare
Contact Us   | Sitemap   | Search  
Home For Patients For Physicians News Room Countries
Avelox
For Physicians
Avelox Tablets Product Information
Related Web Links Physicians
Avelox IV Product Information
Mechanism of Action
Pharmacokinetic Profile
Safety Profile
Special Warnings and Precautions
Molecular Structure
Special Populations
Drug Interactions
Resistance
Antimicrobial Spectrum
Contraindications
Indications
Selected Publications
Overdose
How Supplied

Bayer Links
Bayer Global
Bayer HealthCare
Bayer Pharma Global
General Conditions of Use
Privacy Statement
Copyright and Imprint

  For US Physicians and Patients





Avelox IV Overdose

Quick Search


Only limited data on overdose are available. Single doses of up to 1200 mg and multiple doses of 600 mg over 10 days were administered to healthy subjects without any significant undesirable effects. In the event of overdosage, it is recommended that appropriate supportive care including ECG measurements should be instituted as dictated by patient's clinical status.

After intravenous drug administration carbo medicinalis only slightly reduces systemic exposure (approximately 20%).

The use of oral charcoal early after oral administration may be useful to prevent excessive increase of systemic exposure to Avelox in cases of overdosage. Concomitant dosing of charcoal and 400 mg oral Avelox reduced the systemic availability of the drug by more than 80% by preventing absorption in vivo.


Send Send this article to a friend
Print Printer Friendly Version